Evaluation of the Efficacy and Safety of MV140

NCT02543827 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infection Bacterial

Interventions

BIOLOGICAL: MV140
BIOLOGICAL: Placebo

Sponsor

Inmunotek S.L.